Bend Research Hires Environics Communications As National PR Agency
ProofMay 7, 2012
Established in 1975, Bend Research uses its science and engineering expertise to develop and commercialize pharmaceutical technologies that help advance new medicines to improve human health. Environics will develop and implement a traditional and digital communications program to communicate capabilities, new offerings, and scientific content of interest to clients within the pharmaceutical industry and broader business community nationwide.
“We were impressed with Environics’ ability to generate trade and consumer media interest in complex pharmaceutical and scientific subjects, based on their work with clients such as the American Association of Pharmaceutical Scientists,” said Bend Research CEO and Chairman Rod Ray. “We look forward to working with Environics as we further expand our business both in pharmaceutical research and in other scientific areas.”
“Bend Research makes a unique and critically important contribution to the drug development process, helping pharmaceutical clients take their newest drug discoveries from the lab to the patient,” said Environics U.S. General Manager Dave Groobert. “We’re pleased to add Bend Research to the growing client roster of our U.S. health sciences practice.”
About Bend Research
For more than 35 years, Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company’s ability to develop, and commercialize pharmaceutical technologies, which grow from a solid base of scientific and engineering fundamental understanding. Bend Research provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical-trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. Bend Research is a leader in biotherapeutics technologies and novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion; and controlled-release, inhalation, and nanoparticle technologies. The company has more than 250 employees based in four state-of-the-art facilities in Bend, Ore., USA.